Can Its Existing Production Capacity Drive Growth Without Heavy Capex? 

Synopsis: In Q1 FY27, Cosmo First’s consolidated revenue increased 45.8% YoY to Rs.1,166 crore. The company’s Rs.1,200 crore capital expenditure cycle is almost finished, and its near-term growth now depends on making use of the capacity that has already been built.

Over the past three years, India’s flexible packaging films industry which is valued at about 13,000 crore for BOPP alone and is expanding at an annual rate of 8–10% has absorbed a wave of new capacity from manufacturers vying for premium speciality applications and export demand. 

Investors are increasingly questioning whether the capacity already built can generate enough incremental revenue to justify the money spent on it without further heavy spending. This question is now colliding with that investment phase.

Shares of Cosmo First last closed at Rs.904.20, down  2.10% from the previous close of around Rs.923.55, valuing the packaging films maker at a market capitalisation of Rs.2,373.50 crore. The stock trades at a trailing P/E of 14.23 times.

Revenue Growth Outpaces Cost Growth, But Margins Slip YoY

While PAT increased 25.6% to Rs.54 crore and EBITDA grew more slowly at 26.7% to Rs.147 crore, Cosmo First’s consolidated revenue increased 45.8% YoY to Rs.1,166 crore in Q1 FY27 from Rs.800 crore in Q1 FY26. Revenue growth outpaced raw-material-linked realisations rather than reflecting true demand-led pricing power, resulting in a lower EBITDA margin of 12.6%, down from 14.5% a year earlier.

Revenue increased 14.2% from Rs.1,021 crore in Q4 FY26, EBITDA increased 13.1% from Rs.130 crore, and PAT increased a sharper 45.9% from Rs.37 crore, all thanks to a lower effective tax rate quarter over quarter. Sales volumes increased 9% year over year in Q1, providing the strongest evidence to date that the new lines that have been commissioned over the past year are beginning to find buyers rather than being idle.

The Capex Cycle Is Ending, Utilisation Is the New Growth Lever

Cosmo First’s BOPP, CPP, coating, and metallizing lines have deployed more than 1,200 crore over the last three years, including a new 81,200-MT BOPP line that was commissioned in May 2025 and cost more than 400 crore. The growth algorithm switches from capacity addition to capacity utilisation, a materially different and less capital-intensive route to earnings growth if it succeeds, since management has stated that no significant BOPP capex is planned for the upcoming years.

The investment case revolves around that unproven premise. According to previous management commentary, fully utilising the installed base could theoretically add 25–30% more output, with the newer BOPP and CPP lines carrying the largest utilisation gap. Investors are left to rely mostly on the utilisation thesis for the time being because the company has not provided a clear timeline for closing the gap, and while the 9% YoY volume growth in Q1 is a start, it is only a small portion of that potential.

Newer Businesses Are Growing Faster Than the Core, But Off a Small Base

In Q1, Speciality Chemicals’ revenue increased 34% year over year to 66 crore, while its EBITDA margin increased by 200 basis points to 26%. The pet-care platform Zigly increased net sales 70% YoY to Rs.18 crore, while Cosmo Plastech, the rigid packaging division, increased revenue 58% YoY to Rs.32 crore and became EBIT-positive at a 7% normalised margin. In contrast to the projected 20% growth in consolidated revenue, management anticipates that these four newer companies will grow by about 60% in FY27.

Here, the maths is important. Since films continue to generate the vast majority of revenue, even at 60% growth, the newer companies are still too small on their own to significantly affect consolidated numbers in the near future. Although diversification is directionally significant for return ratios and margin quality over a multi-year period, it is still not a replacement for the core film business that generates growth driven by utilisation.

Debt Is Flat, Not Falling, Despite Higher Earnings

As of June 2026, net debt was Rs.1,166 crore, or 2.3 times EBITDA; in March, it was Rs.1,159 crore, or 2.4 times EBITDA. The money that improved earnings would have otherwise freed up for deleveraging was absorbed by a Rs.85 crore increase in working capital, which was caused by higher raw material prices after the conflict in West Asia. Although Q1 demonstrates how easily commodity-price volatility can offset operating gains on the balance sheet, management is aiming for a reduction to less than 2.0 times EBITDA within 12 to 18 months.

What Should Investors Look Out For

Although the utilisation story management is not yet selling, the Q1 numbers confirm growth. Over the next two to three quarters, investors should monitor whether volume growth significantly accelerates beyond the current 9% YoY pace, as this is the main piece of evidence supporting the capex-behind-us thesis. Instead of just remaining constant, net debt/EBITDA trending significantly below the current 2.3 times would indicate that earnings growth is finally turning into deleveraging rather than being absorbed by fluctuations in working capital. 

Instead of the current 12.6%, an EBITDA margin recovery back towards the 14–15% range observed a year ago would show that pricing power is returning along with volume, not just revenue inflated by raw-material pass-through. Consolidated profitability will actually move from here due to the smaller revenue base of the newer companies and their EBITDA contribution rather than just their percentage growth rates.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.